SynDermix-logo-thumb

Well beyond tomorrow

SynDermix is a Swiss clinical-stage biotechnology company specialising in the development of leading-edge biopharmaceuticals and medical devices in areas of high unmet medical need.

More about SynDermix…

 

Our Technologies

Our pipeline is powered by 3 novel technologies: plant lectins, nitric oxide and vibration therapies.

Core Therapeutic Areas

We are working to develop ground-breaking therapies in the therapeutic areas of cancer supportive care, ENT, dermatology and gastroenterology.

Diversified Pipelines

Our technologies provide platforms for sustained innovation to address multiple health indications while simultaneously driving a wellcare pipeline.

Pipeline overview…

Investors

SynDermix is funded by private investors and is preparing to list in the SIX Swiss Stock Exchange in 2019.